Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial.
Sedighi F, Zarghami M, Alizadeh Arimi F, Moosazadeh M, Ala S, Ghasemian R, Mehravaran H, Elyasi F. Sedighi F, et al. Among authors: ala s. Neuropsychopharmacol Rep. 2023 Jun;43(2):202-212. doi: 10.1002/npr2.12327. Epub 2023 Mar 20. Neuropsychopharmacol Rep. 2023. PMID: 36941089 Free PMC article. Clinical Trial.
The Effectiveness of Catheter Ablation in the Management of Ventricular Tachycardia in Comparison With Antiarrhythmic Drugs in Patients With Structural Heart Disease: A Meta-Analysis.
Karedath J, Valle Villatoro AL, Faisal S, Kathuria Anand I, Anirudh Chunchu V, Umer M, Ala S, Amin A. Karedath J, et al. Among authors: ala s. Cureus. 2023 Jan 10;15(1):e33608. doi: 10.7759/cureus.33608. eCollection 2023 Jan. Cureus. 2023. PMID: 36788893 Free PMC article. Review.
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.
Nekoukar Z, Ala S, Moradi S, Hill A, Davoudi Badabi AR, Alikhani A, Alian S, Moghimi M, Shabani AM, Abbaspour Kasgari H. Nekoukar Z, et al. Among authors: ala s. Iran J Pharm Res. 2021 Fall;20(4):278-288. doi: 10.22037/ijpr.2021.115157.15243. Iran J Pharm Res. 2021. PMID: 35194446 Free PMC article.
65 results